Interestingly, CMS bone marrow mononuclear cells were reported to have an increased Akt expression that promotes erythroblasts survival and decreases apoptosis in CMS patients with excessive erythrocytosis (Zhao et al., 2017a). This evidence concerns the gene AKT1 and polycythemia.